$GERN Recent Headlines Charting the latest market whipsaw

New Post Public Reply Private Reply Replies (0) Message Board

Dec 26, 2013 at 6:09 PM

$GERN Recent Headlines

Charting the latest market whipsaw 10:59 a.m. Nov. 11, 2013 - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Amylin and Alkermes shine in drug-stocks trading 2:08 p.m. July 8, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Regeneron, Cephalon boost biotech stocks 2:29 p.m. May 2, 2011 - Val Brickates Kennedy
Stem cell researchers gain on U.S. court decision 9:14 a.m. May 2, 2011 - Val Brickates Kennedy
StemCells shares climb on spinal injury study 2:49 p.m. March 14, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:09 p.m. Dec. 7, 2010 - Kate Gibson

2013 Wrap-Up And Trading Set Review - Part I 2:53 p.m. Today - Seeking Alpha
Trade-Ideas: Geron Corporation (GERN) Is Today's "Perilous Reversal" Stock 10:32 a.m. Dec. 24, 2013 - TheStreet.com
Cramer's Lightning Round - Tenet Has Made Its Move (12/11/13) 6:06 a.m. Dec. 12, 2013 - Seeking Alpha
'Mad Money' Lightning Round: I Believe in Advanced Micro Devices 6:00 a.m. Dec. 12, 2013 - TheStreet.com
Geron: A Good Time To Buy 7:43 a.m. Dec. 11, 2013 - Seeking Alpha
Geron: Is Imetelstat The 'Aspirin' Of Cancer? 2:58 a.m. Dec. 11, 2013 - Seeking Alpha
Geron Gets a Lift From Good Data 1:25 p.m. Dec. 10, 2013 - Barrons.com
Geron's Game-Changing Myelofibrosis Drug Story Has a Familiar Feel 11:09 a.m. Dec. 10, 2013 - TheStreet.com
Geron Corporation (GERN) Marked As A Dead Cat Bounce Stock 9:45 a.m. Dec. 10, 2013 - TheStreet.com
An Update On 2 Promising But Speculative Biotech Plays 9:35 a.m. Dec. 10, 2013 - Seeking Alpha
Jakafi competition still a ways off: Canaccord 8:11 a.m. Dec. 10, 2013 - Seeking Alpha
Analysts weigh in on Geron after upbeat imetelstat ASH presentation 7:52 a.m. Dec. 10, 2013 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Celgene, Goldman, Geron and More 7:44 a.m. Dec. 10, 2013 - 247WallSt.com
Benzinga's Top #PreMarket Gainers 7:11 a.m. Dec. 10, 2013 - benzinga.com
Benzinga's Top Upgrades 7:00 a.m. Dec. 10, 2013 - benzinga.com
Geron Corporation - Shareholder/Analyst Call 2:30 a.m. Dec. 10, 2013 - Seeking Alpha
Geron's CEO Hosts ASH 2013 Analyst and Investor Conference (Transcript) 2:30 a.m. Dec. 10, 2013 - Seeking Alpha
Geron presents imetelstat data at ASH, shares rise 9:41 p.m. Dec. 9, 2013 - Seeking Alpha
Not much new in Mayo Geron article: Needham 9:52 a.m. Dec. 6, 2013 - Seeking Alpha
Today's Pre-Market Mover With Heavy Volume: Geron Corporation (GERN) 8:35 a.m. Dec. 6, 2013 - TheStreet.com

Important Trend Analysis: Amarin Corporation plc, Corporation, Geron Corporation, 3D Systems Corporation 10:22 a.m. Dec. 20, 2013 - ACCESSWIRE
Updated Estimates, Stock Movements, and Regulatory Approvals - Research Report on Quest Diagnostics, Zimmer Holdings, Pacira Pharmaceuticals, Geron, and Oculus Innovative Sciences 8:00 a.m. Dec. 18, 2013 - PR Newswire
Bullish Momentum Stocks: Geron Corporation, 3D Systems Corporation, Eagle Bulk Shipping, Finisar Corporation, J.C. Penney Company 9:26 a.m. Dec. 10, 2013 - PR Newswire
Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron, Ligand Pharmaceuticals, Masimo, and Capital Senior Living 8:00 a.m. Dec. 10, 2013 - PR Newswire
Top Gainers & Losers: InterOil Corporation, Geron Corporation, Amazon.com, ZIOPHARM Oncology Inc 9:46 a.m. Dec. 6, 2013 - ACCESSWIRE
Geron to Host Analyst and Investor Meeting on December 9 7:30 a.m. Dec. 5, 2013 - Thomson Reuters ONE
Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune 8:00 a.m. Dec. 2, 2013 - PR Newswire
Geron to Present at the Piper Jaffray Healthcare Conference 7:30 a.m. Nov. 26, 2013 - Thomson Reuters ONE
Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc. 1:31 p.m. Nov. 22, 2013 - PR Newswire
Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Nov. 12, 2013 - PR Newswire
Earning Forecast Tips for Hot Stocks: Facebook, Tesla, J.C. Penney, Groupon, Geron, and Alcoa 9:00 a.m. Nov. 8, 2013 - PR Newswire
TrendingWallStreet.com Initiates Volume Analysis on TWTR, FNMA, SEEK, and GERN 12:18 a.m. Nov. 8, 2013 - ACCESSWIRE
Geron Corporation Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - Thomson Reuters ONE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results 4:00 p.m. Nov. 1, 2013 - Thomson Reuters ONE
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences 8:00 a.m. Oct. 21, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
TSLA, AGNC, GERN and ZLCS added to Nasdaq Active Stock Watch List at GSR 9:04 a.m. Oct. 1, 2013 - ACCESSWIRE
Geron Completes Divestiture of Stem Cell Assets 9:00 a.m. Oct. 1, 2013 - Thomson Reuters ONE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Machine Grabs Prime Dallas Property Amid Apartment Boom

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....